Delivery Order SPE2DB25D3022-SPE2DB25FWCBA
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $3,707.03 order is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. This delivery order is part of an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, to provide a comprehensive...
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,905.74 firm fixed-price delivery order is for the supply of MOVANTIK 12.5 MG TABLET 30S, with a completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price of $1,405.17 and a period of performance through February 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $7,869.78 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 30 tablets of Movantik, a medication used to treat opioid-induced constipation, to an unspecified location in Conshohocken, Pennsylvania. The single-award delivery order was issued on September 12, 2023 under an existing Amerisourcebergen contract vehicle and has a period of performance through September...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of the drug MOVANTIK 25 MG TABLET 30S. The Firm Fixed Price, Delivery Order contract has a ceiling value of $1,077.16 and a period of performance through March 13, 2025. The contract is not designated under any set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Movantik 25 mg tablets to the Defense Logistics Agency (DLA). The $1,174.80 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,288.17 fixed-price delivery order is for the medication MOVANTIK 25 MG TABLET 30S. The contract has an ultimate completion date of April 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, which provides a comprehensive range...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $251.82 to Amerisourcebergen Drug Corporation for 30 tablets of Movantik 12.5 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from August 10, 2023 through August 11, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports military readiness by procuring, managing and...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,602.26 firm fixed price contract is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCBADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Movantik (naloxegol) 25 mg tablets in unit dose packaging (100 count), valued at $2,631.75. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Movantik is an oral opioid antagonist commonly used in military and Department of Defense healthcare settings to manage opioid-induced constipation. The SPE2DX contract represents a prime vendor arrangement enabling AmerisourceBergen to supply a broad range of pharmaceuticals, medical devices, and specialized healthcare commodities to support Defense Health Agency operations, the U.S. Coast Guard, and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/28/25 |